Example: Heart Attack
Clinical Trials Sponsored by Cyclacel Pharmaceuticals, Inc
Total 16 results
-
NCT04017546RecruitingConditions: AML; MDS
-
NCT03884829RecruitingConditions: AML, Adult; Myelodysplastic Syndromes; ALL, Adult; CML, Refractory; CLL, Refractory
-
NCT03739554RecruitingConditions: Relapsed or Refractory Chronic Lymphocytic Leukemia
-
NCT02552953RecruitingConditions: Cancer
-
NCT01303796CompletedConditions: Acute Myeloid Leukemia
-
NCT01211457Unknown statusConditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes
-
NCT00999401Unknown statusConditions: Advanced Solid Tumors
-
NCT00885963TerminatedConditions: Non-small Cell Lung Cancer
-
NCT00590187CompletedConditions: Acute Myeloid Leukemia
-
NCT00560716TerminatedConditions: Solid Tumors
-
NCT00476554TerminatedA Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaConditions: Cutaneous T-cell Lymphoma (CTCL)
-
NCT00380653CompletedConditions: Leukemias; Myelodysplastic Syndromes
-
NCT00372073TerminatedConditions: Non-small Cell Lung Cancer
-
NCT03641755RecruitingConditions: Breast Cancer
-
NCT02649751TerminatedConditions: Cystic Fibrosis
-
NCT01253460TerminatedConditions: Leukemia